Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Ranging Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Subjects With Gastroparesis
Sponsor: Evoke Pharma
Listed as NCT00845858, this PHASE2 trial focuses on Delayed Gastric Emptying and Diabetes and remains completed. Sponsored by Evoke Pharma, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Apr 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Evoke Pharma
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Akron, United States , Albuquerque, United States , Anderson, United States , Austin, United States , Baytown (Houston), United States , Beverly Hills, United States , Boston, United States , Boynton Beach, United States , Charlottesville, United States , Chesapeake, United States and 48 more locations